v3.25.2
Related Party Transactions (Tables)
12 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions

Nature of relationships with related parties

 

Name of related parties   Relationship with the Company
     
Feng Zhou   Major shareholder of the Company, Chief Executive Officer
Jun Zheng   Director of the Company
Xiaodong Ji   Independent Director of the Company
Taizhou Jiutian Pharmaceutical Co. Ltd.   An entity controlled by Jianping Zhou
Jiangsu Health   An entity controlled by Jianping Zhou
Taizhou Su Xuan Tang Chinese Medicine Clinic   An entity controlled by Jianping Zhou
Taizhou Su Xuan Tang Chinese hospital Co., Ltd.   An entity controlled by Jianping Zhou
Jiangsu Sutaitang Online Commercial Co., Ltd.   An entity controlled by Xiaodong Ji

The amounts due from related parties as of March 31, 2025 and 2024 were as follows: 

 

   As of March 31, 
   2025   2024 
         
Jiangsu Sutaitang Online Commercial Co., Ltd.  $370,862   $
       -
 
Taizhou Su Xuan Tang Chinese hospital Co., Ltd.   41,561    
-
 
Taizhou Su Xuan Tang Chinese Medicine Clinic   5,140    
-
 
Total due from related parties  $417,563   $
-
 

 

The amounts due to related parties as of March 31, 2025 and 2024 were as follows: 

 

   As of March 31, 
   2025   2024 
         
Jiangsu Health  $
-
   $1,047,550 
Total due to related parties  $
        -
   $1,047,550 
These related party transactions were conducted in the ordinary course of business of the Company.
   For the years ended March 31, 
   2025   2024   2023 
             
Taizhou Su Xuan Tang Chinese Hospital Co. Ltd.   1,621    25,528    17,478 
Taizhou Su Xuan Tang Chinese Medicine Clinic   1,091    2,232    11,533 
Taizhou Jiutian Pharmaceutical Co. Ltd.   1,589    
-
    4,610 
Total revenue generated from related parties  $4,301   $27,760   $33,621